반응형
전 세계와 한국의 코로나 19 백신 접종 현황
Our World in Data(OWID) 백신 통계에 따르면 6월 19일 현재 세계 인구의 21.5%, 16억8천만 명이 적어도 1회 이상의 코로나 19 백신을 투여받았다. 이 가운데 백신 접종이 완료된 인구는 7억6천만 명이다.
한국은 6월 17일 현재 백신 접종이 완료된 인구는 7.6%(388만 명), 부분적으로 접종을 받은 인구는 20.1%(1,035만 명)이다. 질병 관리청의 6월 20일 현재 통계에 따르면 접종 완료자는 404만 명이며, 1차 접종 완료자는 1,501만 명으로 증가했다.
1백 명당 1일 접종량을 보면, 전 세계 평균은 1일 1백 명당 0.48명이 백신을 접종받고 있다. 한국은 6월 17일 현재 1백 명당 1.37명이 백신을 접종받고 있으며, 전 세계에서 가장 빠르게 백신 주사가 투여되고 있는 나라다.
전 세계와 한국의 백신 투여량과 백신 불평등
전 세계적으로 26억 회의 백신이 투여되었고, 현재 매일 3,610만 회가 투여되고 있다. 코로나 19 백신에 따라 접종 완료까지 투여량은 1회 혹은 2회로 각기 다르다. 아래 도표는 1백 명당 백신 투여량을 표시한 것이다. 접종 완료까지 2회 접종을 요구하는 백신들이 많기에 1백 명당 투여량은 100을 넘을 수 있다. 세계 평균은 100명당 33.63회이며, 아랍에미리트가 1백 명당 145회로 가장 높으며, 한국은 6월 17일 현재 35회이다.
대륙별로 백신 투여량은 큰 차이를 보인다. 아시아 대륙은 지금까지 15억5천만 회의 백신이 투여되어 전체의 58.94%를 차지하고 있지만, 오세아니아는 800만 회로 0.3%, 아프리카는 4,281만 회로 1.65%, 남아프리카는 1억5,666만 회로 5.99%를 차지하고 있다. 이 비율은 대륙별 인구 차이로 인해 백신의 실질적인 공급 현황을 제대로 반영하지 못한다.
소득별 백신 투여량을 보면 세계적으로 백신 공급의 불평등이 심각함을 알 수 있다. 고소득 국가는 지금까지 투여된 백신의 약 34%를 차지하고 있으며, 중상위 소득 국가들은 51.44%로 가장 많은 백신이 투여됐다. 하지만 저소득국가에 대한 백신 투여는 겨우 0.29%에 그치고 있다.
국가 및 지역별 사용 중인 백신 종류
전 세계적으로 가장 많이 사용되고 있는 백신은 아래 도표에서도 나오듯이 옥스퍼드-아스트라제네카 백신이다. 하지만 나라별로 어떤 백신을 어느 정도 사용하고 있는지에 대한 자료는 많지 않다. 지금까지 나와 있는 일부 자료들에 근거해서 보면, 각 나라들은 다양한 종류의 백신을 사용하고 있으며, 나라별 주력 백신도 다르다. 유럽 대륙에서는 화이자-바이오엔테크와 옥스퍼드-아스트라제네카가 주력 백신이며, 동구권에서는 화이자-바이오엔테크와 옥스퍼드-아스트라제네카, 스푸트니크V, 남미에서는 시노백과 화이자-바이오엔테크가 주력 백신임을 알 수 있다.
독일은 6월 18일 현재 총 6,674만 회의 백신 중 화이자-바이오엔테크 백신이 4,827만 회, 옥스퍼드-아스트라제네카가 1,041만 회, 모더나가 543만 회, 존슨앤드존슨(얀센)이 163만 회 투여되었다.
미국은 6월 19일 현재 총 3억1,687만 회의 백신 중 화이자-바이오엔테크가 1억7,397만 회, 모더나가 1억3,097회, 존슨앤드존슨(얀센)이 1,193만 회가 투여되었다.
네덜란드는 6월 18일 현재 1,292만 회의 백신 투여 중 화이자-바이오엔테크가 908만 회, 옥스퍼드-아스트라제네카가 241만 회, 모더나가 99만 회, 존슨앤드존슨(얀센)이 43만 회가 투여되었다.
칠레는 6월 15일 현재 2,087만 회의 백신 중 시노백 백신이 1,651만 회, 화이자-바이오엔태크가 377만 회, 옥스퍼드-아스트라제네카가 37만 회, 캔시노가 20만 회 투여되었다.
헝가리는 6월 18일 현재 954만 회의 백신이 투여됐고, 그중 화이자-바이오엔테크가 402만 회, 시노팜이 203만 회, 스푸트니크V가 179만 회, 옥스퍼드-아스트라제네카가 101만 회, 모더나가 61만 회 투여되었다.
한국은 질병관리청에 따르면, 6월 20일 현재 1차 접종 29.2% 중 옥스퍼드-아스크라제네카(AZ)백신은 1,037만 2,923명, 화이자-바이오엔테크 백신은 352만 명, 존슨앤드존슨(얀센)은 111만 명이 접종받았다.
전 세계 212개국/지역에서 사용 중인 백신을 순서대로 보면, 옥스퍼드-아스트라제네카는 전 세계 178개국/지역, 화이자-바이오엔테크는 104개국/지역, 모더나는 54개국/지역, 스푸트니크V는 45개국/지역, 시노팜/베이징은 45개국/지역, 시노백은 32개국/지역, 존슨앤드존슨(얀센)은 26개국/지역, 시노팜 BBIBP-CorV는 15개국/지역, 코바신(Covaxin)은 6개국/지역, 러시아의 에피박코로나(EpiVacCorona)는 2개국/지역에서 사용되고 있다.
| 국가/지역 |
출처 | 최종 확인 날짜 | 투입 백신 종류 |
| Afghanistan | World Health Organization | Jun. 14, 2021 | BBIBP-CorV, Oxford/AstraZeneca, Pfizer/BioNTech |
| Albania | Ministry of Health | Jun. 17, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Algeria | Ministry of Health | Jun. 6, 2021 | Oxford/AstraZeneca, Sputnik V |
| Andorra | Government of Andorra | Jun. 14, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Angola | World Health Organization | Jun. 15, 2021 | Oxford/AstraZeneca |
| Anguilla | World Health Organization | Jun. 11, 2021 | Oxford/AstraZeneca |
| Antigua and Barbuda | Ministry of Health | Jun. 15, 2021 | Oxford/AstraZeneca |
| Argentina | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V |
| Armenia | Ministry of Health | Jun. 14, 2021 | Oxford/AstraZeneca, Sinovac, Sputnik V |
| Aruba | Government of Aruba | Jun. 18, 2021 | Pfizer/BioNTech |
| Australia | Government of Australia via covidlive.com.au | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Austria | Ministry of Health | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Azerbaijan | Government of Azerbaijan | Jun. 18, 2021 | Oxford/AstraZeneca, Sinovac, Sputnik V |
| Bahamas | Government of the Bahamas | Jun. 11, 2021 | Oxford/AstraZeneca |
| Bahrain | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Bangladesh | Directorate General of Health Services | Jun. 19, 2021 | Oxford/AstraZeneca |
| Barbados | Ministry of Health | Jun. 17, 2021 | Oxford/AstraZeneca |
| Belarus | World Health Organization | Jun. 13, 2021 | BBIBP-CorV, Sputnik V |
| Belgium | Sciensano | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Belize | Ministry of Health | Jun. 17, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Benin | Ministry of Health | Jun. 8, 2021 | Oxford/AstraZeneca, Sinovac |
| Bermuda | Government of Bermuda | Jun. 14, 2021 | Pfizer/BioNTech |
| Bhutan | World Health Organization | Jun. 13, 2021 | Oxford/AstraZeneca |
| Bolivia | Ministry of Health | Jun. 18, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Bonaire Sint Eustatius and Saba | World Health Organization | Apr. 9, 2021 | Moderna, Pfizer/BioNTech |
| Bosnia and Herzegovina | Public Health Institute | Jun. 13, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Botswana | Ministry of Health and Wellness | Jun. 7, 2021 | Oxford/AstraZeneca |
| Brazil | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| British Virgin Islands | World Health Organization | Jun. 11, 2021 | Oxford/AstraZeneca |
| Brunei | Ministry of Health | Jun. 17, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Bulgaria | Ministry of Health | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Burkina Faso | World Health Organization | Jun. 14, 2021 | Oxford/AstraZeneca |
| Cambodia | Ministry of Health | Jun. 16, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac |
| Cameroon | World Health Organization | Jun. 14, 2021 | BBIBP-CorV, Oxford/AstraZeneca |
| Canada | Official data from provinces via covid19tracker.ca | Jun. 19, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Cape Verde | World Health Organization | Jun. 15, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Cayman Islands | Cayman Islands Government | Jun. 18, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Central African Republic | World Health Organization | Jun. 15, 2021 | Covaxin, Oxford/AstraZeneca |
| Chad | World Health Organization | Jun. 10, 2021 | BBIBP-CorV |
| Chile | Department of Statistics and Health Information via github.com/juancri/covid19-vaccination | Jun. 15, 2021 | CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| China | National Health Commission | Jun. 19, 2021 | CanSino, Sinopharm/Beijing, Sinopharm/Wuhan, Sinovac |
| Colombia | Ministry of Health | Jun. 17, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Comoros | World Health Organization | Jun. 8, 2021 | Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing |
| Congo | World Health Organization | Jun. 15, 2021 | BBIBP-CorV, Moderna, Oxford/AstraZeneca, Sputnik V |
| Cook Islands | SPC Public Health Division | Jun. 15, 2021 | Oxford/AstraZeneca |
| Costa Rica | Costa Rican Social Security Fund | Jun. 14, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Cote d’Ivoire | Ministry of Health and Public Hygiene | Jun. 18, 2021 | Oxford/AstraZeneca |
| Croatia | Ministry of Health | Jun. 18, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Cuba | Ministry of Health | Jun. 17, 2021 | Abdala, Soberana02 |
| Curacao | Government of Curacao | Jun. 19, 2021 | Moderna, Pfizer/BioNTech |
| Cyprus | Ministry of Health | Jun. 17, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Czechia | Ministry of Health | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Democratic Republic of Congo | World Health Organization | Jun. 14, 2021 | Oxford/AstraZeneca |
| Denmark | Statens Serum Institute | Jun. 18, 2021 | Johnson&Johnson, Moderna, Pfizer/BioNTech |
| Djibouti | World Health Organization | Jun. 1, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V |
| Dominica | Government of Dominica | Jun. 14, 2021 | Oxford/AstraZeneca |
| Dominican Republic | Ministry of Public Health | Jun. 18, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac |
| Ecuador | Government of Ecuador via Ecuacovid | Jun. 15, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Egypt | World Health Organization | Jun. 16, 2021 | BBIBP-CorV, Oxford/AstraZeneca, Sinovac, Sputnik V |
| El Salvador | Ministry of Health | Jun. 18, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| England | Government of the United Kingdom | Jun. 18, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Equatorial Guinea | Ministry of Health | Jun. 17, 2021 | Sinopharm/Beijing |
| Estonia | National Health Board | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Eswatini | Government of Eswatini | May. 13, 2021 | Oxford/AstraZeneca |
| Ethiopia | Ministry of Health | Jun. 18, 2021 | Oxford/AstraZeneca |
| Faeroe Islands | Government of the Faeroe Islands | Jun. 19, 2021 | Moderna, Pfizer/BioNTech |
| Falkland Islands | Government of the Falkland Islands | Apr. 14, 2021 | Oxford/AstraZeneca |
| Fiji | SPC Public Health Division | Jun. 15, 2021 | Oxford/AstraZeneca |
| Finland | Finnish Institute for Health and Welfare | Jun. 19, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| France | Public Health France | Jun. 18, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| French Polynesia | SPC Public Health Division | Jun. 15, 2021 | Oxford/AstraZeneca |
| Gabon | Ministry of Health | Jun. 18, 2021 | Sinopharm/Beijing |
| Gambia | World Health Organization | Jun. 8, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Georgia | Government of Georgia | Jun. 19, 2021 | Oxford/AstraZeneca |
| Germany | Robert Koch Institut | Jun. 18, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Ghana | World Health Organization | May. 31, 2021 | Oxford/AstraZeneca, Sputnik V |
| Gibraltar | Government of Gibraltar | Jun. 12, 2021 | Pfizer/BioNTech |
| Greece | Ministry of Health | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Greenland | Government of Greenland | Jun. 18, 2021 | Moderna |
| Grenada | World Health Organization | Jun. 11, 2021 | Oxford/AstraZeneca |
| Guatemala | Ministry of Health | Jun. 18, 2021 | Moderna, Oxford/AstraZeneca |
| Guernsey | Government of Guernsey | Jun. 18, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Guinea | National Health Security Agency | Jun. 17, 2021 | Sputnik V |
| Guinea-Bissau | World Health Organization | Jun. 8, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Guyana | Ministry of Health | Jun. 16, 2021 | Oxford/AstraZeneca, Sputnik V |
| Honduras | World Health Organization | Jun. 17, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Sputnik V |
| Hong Kong | Government of Hong Kong | Jun. 19, 2021 | Pfizer/BioNTech, Sinovac |
| Hungary | Government of Hungary | Jun. 17, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Iceland | Directorate of Health | Jun. 17, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| India | Government of India | Jun. 19, 2021 | Covaxin, Oxford/AstraZeneca |
| Indonesia | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca, Sinovac |
| Iran | World Health Organization | Jun. 14, 2021 | BBIBP-CorV, Covaxin, Oxford/AstraZeneca, Sputnik V |
| Iraq | World Health Organization | Jun. 14, 2021 | BBIBP-CorV, Oxford/AstraZeneca, Pfizer/BioNTech, Sputnik V |
| Ireland | Heath Service Executive | Jun. 13, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Isle of Man | Isle of Man Government | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Israel (see FAQ) | Government of Israel | Jun. 19, 2021 | Moderna, Pfizer/BioNTech |
| Italy | Extraordinary commissioner for the Covid-19 emergency | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Jamaica | World Health Organization | Jun. 11, 2021 | Oxford/AstraZeneca |
| Japan | Prime Minister’s Office | Jun. 17, 2021 | Moderna, Pfizer/BioNTech |
| Jersey | Government of Jersey | Jun. 13, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Jordan | Government of Jordan | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Kazakhstan | Government of Kazakhstan | Jun. 19, 2021 | QazVac, Sinopharm/HayatVax, Sputnik V |
| Kenya | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca, Sputnik V |
| Kosovo | Ministry of Health | Jun. 13, 2021 | Oxford/AstraZeneca |
| Kuwait | Ministry of Health | Jun. 13, 2021 | Pfizer/BioNTech |
| Kyrgyzstan | Ministry of Health | Jun. 9, 2021 | Sinopharm/Beijing, Sputnik V |
| Laos | Government of Laos | Jun. 18, 2021 | Sinopharm/Beijing, Sputnik V |
| Latvia | National Health Service | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Lebanon | Government of Lebanon | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Lesotho | World Health Organization | May. 21, 2021 | Oxford/AstraZeneca |
| Liberia | World Health Organization | Jun. 15, 2021 | Oxford/AstraZeneca |
| Libya | World Health Organization | Jun. 16, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Liechtenstein | Federal Office of Public Health | Jun. 16, 2021 | Moderna, Pfizer/BioNTech |
| Lithuania | Ministry of Health | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Luxembourg | Government of Luxembourg | Jun. 18, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Macao | Government of Macao | Jun. 19, 2021 | Pfizer/BioNTech, Sinopharm/Beijing |
| Madagascar | World Health Organization | Jun. 15, 2021 | Oxford/AstraZeneca |
| Malawi | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca |
| Malaysia | Government of Malaysia | Jun. 18, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Maldives | Presidency of the Maldives | Jun. 17, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Mali | World Health Organization | Jun. 14, 2021 | Oxford/AstraZeneca |
| Malta | COVID-19 Malta Public Health Response Team | Jun. 18, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Mauritania | World Health Organization | Jun. 15, 2021 | BBIBP-CorV, Oxford/AstraZeneca |
| Mauritius | World Health Organization | Jun. 8, 2021 | Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing |
| Mexico | Secretary of Health | Jun. 18, 2021 | CanSino, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Moldova | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Monaco | National Council | Jun. 10, 2021 | Pfizer/BioNTech |
| Mongolia | Ministry of Health via ikon.mn | Jun. 18, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Montenegro | Government of Montenegro | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Montserrat | World Health Organization | Jun. 11, 2021 | Oxford/AstraZeneca |
| Morocco | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Mozambique | World Health Organization | Jun. 10, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Myanmar | World Health Organization | May. 13, 2021 | Oxford/AstraZeneca |
| Namibia | Ministry of Health and Social Services | Jun. 19, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Nauru | SPC Public Health Division | Jun. 8, 2021 | Oxford/AstraZeneca |
| Nepal | Government of Nepal | Jun. 19, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Netherlands | RIVM via European CDC | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| New Caledonia | SPC Public Health Division | Jun. 15, 2021 | Pfizer/BioNTech |
| New Zealand | Ministry of Health | Jun. 15, 2021 | Pfizer/BioNTech |
| Nicaragua | World Health Organization | May. 21, 2021 | Oxford/AstraZeneca, Sputnik V |
| Niger | World Health Organization | Jun. 14, 2021 | BBIBP-CorV, Oxford/AstraZeneca |
| Nigeria | Government of Nigeria | Jun. 4, 2021 | Oxford/AstraZeneca |
| North Macedonia | Government of North Macedonia | Jun. 17, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinovac, Sputnik V |
| Northern Cyprus | Ministry of Health | May. 27, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Northern Ireland | Government of the United Kingdom | Jun. 18, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Norway | Norwegian Institute of Public Health | Jun. 17, 2021 | Moderna, Pfizer/BioNTech |
| Oman | World Health Organization | Jun. 15, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Pakistan | National Command and Operation Centre | Jun. 19, 2021 | CanSino, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V |
| Palestine (see FAQ) | Ministry of Health | Jun. 19, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Panama | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Papua New Guinea | World Health Organization | Jun. 7, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Paraguay | Government of Paraguay | Jun. 17, 2021 | Covaxin, Oxford/AstraZeneca, Sinopharm/Beijing, Sinovac, Sputnik V |
| Peru | Ministry of Health | Jun. 18, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing |
| Philippines | Government of the Philippines | Jun. 18, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Pitcairn | SPC Public Health Division | Jun. 15, 2021 | Oxford/AstraZeneca |
| Poland | Ministry of Health | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Portugal | Directorate General for Health via Data Science for Social Good | Jun. 19, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Qatar | Ministry of Public Health | Jun. 19, 2021 | Moderna, Pfizer/BioNTech |
| Romania | Government of Romania via datelazi.ro | Jun. 18, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Russia | Official data from local governments via gogov.ru | Jun. 19, 2021 | EpiVacCorona, Sputnik V |
| Rwanda | World Health Organization | Jun. 6, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Saint Helena | Government of Saint Helena | May. 5, 2021 | Oxford/AstraZeneca |
| Saint Kitts and Nevis | Government of Saint Kitts and Nevis | Jun. 15, 2021 | Oxford/AstraZeneca |
| Saint Lucia | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca |
| Saint Vincent and the Grenadines | Ministry of Health | Jun. 15, 2021 | Oxford/AstraZeneca |
| Samoa | SPC Public Health Division | Jun. 15, 2021 | Oxford/AstraZeneca |
| San Marino | Social Security Institute | Jun. 16, 2021 | Pfizer/BioNTech, Sputnik V |
| Sao Tome and Principe | World Health Organization | Jun. 14, 2021 | Oxford/AstraZeneca |
| Saudi Arabia | Saudi Health Council | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Scotland | Government of the United Kingdom | Jun. 18, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Senegal | World Health Organization | Jun. 15, 2021 | BBIBP-CorV, Oxford/AstraZeneca |
| Serbia | Government of Serbia | Jun. 17, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sputnik V |
| Seychelles | Extended Programme for Immunisation | Jun. 18, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Sierra Leone | World Health Organization | Jun. 14, 2021 | BBIBP-CorV, Oxford/AstraZeneca |
| Singapore | Ministry of Health | Jun. 14, 2021 | Moderna, Pfizer/BioNTech |
| Sint Maarten (Dutch part) | World Health Organization | Jun. 11, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Slovakia | Ministry of Health | Jun. 18, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Slovenia | National Institute of Public Health via covid-19.sledilnik.org | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Solomon Islands | SPC Public Health Division | Jun. 8, 2021 | Oxford/AstraZeneca |
| Somalia | World Health Organization | Jun. 17, 2021 | BBIBP-CorV, Oxford/AstraZeneca, Sinovac |
| South Africa | Ministry of Health | Jun. 17, 2021 | Johnson&Johnson, Pfizer/BioNTech |
| South Korea | Korea Centers for Disease Control and Prevention | Jun. 17, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| South Sudan | World Health Organization | Jun. 14, 2021 | Oxford/AstraZeneca |
| Spain | Ministry of Health | Jun. 17, 2021 | Johnson&Johnson, Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Sri Lanka | Ministry of Health’s Epidemiology Unit | Jun. 19, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V |
| Sudan | World Health Organization | Jun. 14, 2021 | BBIBP-CorV, Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Suriname | Government of Suriname | Jun. 18, 2021 | Oxford/AstraZeneca |
| Sweden | Public Health Agency of Sweden | Jun. 18, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech |
| Switzerland | Federal Office of Public Health | Jun. 16, 2021 | Moderna, Pfizer/BioNTech |
| Syria | World Health Organization | Jun. 6, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V |
| Taiwan | Taiwan Centers for Disease Control | Jun. 18, 2021 | Moderna, Oxford/AstraZeneca |
| Tajikistan | World Health Organization | Jun. 13, 2021 | Oxford/AstraZeneca |
| Thailand | Government of Thailand | Jun. 18, 2021 | Oxford/AstraZeneca, Sinovac |
| Timor | World Health Organization | Jun. 15, 2021 | Oxford/AstraZeneca, Sinovac |
| Togo | World Health Organization | Jun. 10, 2021 | Oxford/AstraZeneca |
| Tonga | SPC Public Health Division | Jun. 1, 2021 | Oxford/AstraZeneca |
| Trinidad and Tobago | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca |
| Tunisia | Ministry of Health | Jun. 16, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac, Sputnik V |
| Turkey | COVID-19 Vaccine Information Platform | Jun. 19, 2021 | Pfizer/BioNTech, Sinovac |
| Turkmenistan | World Health Organization | Apr. 4, 2021 | EpiVacCorona, Oxford/AstraZeneca, Sinopharm/Beijing, Sputnik V |
| Turks and Caicos Islands | World Health Organization | May. 28, 2021 | Pfizer/BioNTech |
| Tuvalu | SPC Public Health Division | Jun. 15, 2021 | Oxford/AstraZeneca |
| Uganda | Ministry of Health | Jun. 15, 2021 | Oxford/AstraZeneca |
| Ukraine | Ministry of Health | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| United Arab Emirates | National Emergency Crisis and Disaster Management Authority | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinopharm/Beijing, Sinopharm/Wuhan, Sputnik V |
| United Kingdom | Government of the United Kingdom | Jun. 18, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| United States | Centers for Disease Control and Prevention | Jun. 19, 2021 | Johnson&Johnson, Moderna, Pfizer/BioNTech |
| Uruguay | Ministry of Health via vacuna.uy | Jun. 19, 2021 | Oxford/AstraZeneca, Pfizer/BioNTech, Sinovac |
| Uzbekistan | Government of Uzbekistan | Jun. 15, 2021 | Oxford/AstraZeneca, RBD-Dimer, Sputnik V |
| Vanuatu | SPC Public Health Division | Jun. 15, 2021 | Oxford/AstraZeneca |
| Venezuela | Government of Venezuela | Jun. 18, 2021 | BBIBP-CorV, Sputnik V |
| Vietnam | Government of Vietnam | Jun. 19, 2021 | Oxford/AstraZeneca |
| Wales | Government of the United Kingdom | Jun. 17, 2021 | Moderna, Oxford/AstraZeneca, Pfizer/BioNTech |
| Wallis and Futuna | SPC Public Health Division | Jun. 15, 2021 | Oxford/AstraZeneca |
| Yemen | World Health Organization | Jun. 16, 2021 | Oxford/AstraZeneca |
| Zambia | Government of Zambia | Jun. 15, 2021 | Oxford/AstraZeneca, Sinopharm/Beijing |
| Zimbabwe | Ministry of Health | Jun. 14, 2021 | Sinopharm/Beijing |
반응형
'코로나19' 카테고리의 다른 글
| 유럽 여행은 언제 쯤 가능할까?: 유럽의 코로나 19 봉쇄조치(lockdown) 해제 상황 (0) | 2021.06.24 |
|---|---|
| '도쿄 2020' 올림픽: 일본은 코로나 19를 통제하고 있는가? (0) | 2021.06.22 |
| 코로나 19, 알파, 베타, 감마, 델타란 명명법(nomenclature)변화의 의미, '우려 변이'와 '관심 변이'의 차이, 그리고 각 변이에 대한 각종 백신 효과 (0) | 2021.06.19 |
| 코로나 19 델타 변이(B.1.617.2), 최근 영국 코로나 19 감염의 99% 차지 (0) | 2021.06.18 |
| 코로나-19 주요 변이(영국, 남아프리카, 브라질, 인도 델타) 전 세계 확산 정도와 백신 효과 (0) | 2021.05.31 |